Effect of <i>Abhaya Ghana Vati</i> along with <i>Pathya Aaahara Vihara</i> (Diet and Lifestyle Regime) on Patients of Diabesity – A Single Arm Clinical Trial

Author:

Joglekar Aishwarya Ashish,Vyas Mahesh,Bhojani Meera K.,Kumar Anil

Abstract

Introduction: Ayurveda beautifully amalgamates herbal drugs and lifestyle modifications in the management of various diseases and lifestyle disorders. Diabesity is one condition representing the two most prevalent chronic non-communicable diseases, i.e., Diabetes and Obesity According to Ayurveda, both conditions are referred to as Prameha and Sthoulya, respectively. Both the conditions are Santarpanottha Vyadhi (diseases arising from excessive and improper nutrition), having the common vitiation of Kapha Dosha, Meda Dhatu and Ama and similar lines of treatment. Haritaki or Abhaya (Terminalia chebula) is a herb that has the potential to manage both diabetes and obesity. The present study focuses on the efficacy of Abhaya Ghana Vati as a single drug regime coupled with Pathya Aahara Vihara (diet and lifestyle regime) in the management of diabesity. Methods: Abhaya Ghana Vati along with Pathya Aahara Vihara (diet and lifestyle regime), was administered in 41 patients for three months, including follow-up. The patients were assessed for the effect of the intervention on the subjective and objective criteria. Results: The intervention showed significant improvement in most of the parameters of outcome measures like BMI (27% improvement, p<0.001), Waist Hip Ratio (p<0.002), Abdominal Girth Circumference (p<0.001), Chest Girth circumference (p<0.001), Waist circumference (p<0.001). The Fasting Blood Sugar (FBS) levels declined significantly from the mean (187.4 to 168.9, p<0.048), and PPBS reduced from the mean (260 to 230.4, p<0.011), which was statistically significant. However, HbA1c declined very marginally from the mean of 8.32 to 8.23 (p<0.71). Effect of treatment on subjective parameters like Apatarpana Lakshana, Dhatusamya Lakshana and Quality of Life parameters showed significant change. Conclusions: Administration of Abhaya Ghana Vati and Pathya Aahara Vihara are beneficial in patients of diabesity.

Publisher

Informatics Publishing Limited

Subject

Pharmacology

Reference18 articles.

1. Chadt A, Scherneck S, Joost H-G, Al-Hasani H. Molecular links between obesity and diabetes: “Diabesity” [Internet]. 2000. In: Feingold KR, Anawalt B, Boyce A, et al., editors. Endotext. South Dartmouth (MA): MDText.com, Inc. Available from: https://www.ncbi.nlm.nih.gov/books/ NBK279051/

2. Wells JCK. The diabesity epidemic in the light of evolution: Insights from the capacity load model. Diabetologia. 2019; 62(10):1740-50. https://doi.org/10.1007/s00125-019-4944-8

3. The Institute for Health Metrics and Evaluation. Global diabetes cases to soar from 529 million to 1.3 billion by 2050 [Internet]. 2023. [cited 2023 Aug 26]. Available from: https://www.healthdata.org/newsevents/newsroom/newsreleases/global-diabetes-cases-soar-529-million-13billion-2050

4. Sharma S. Ashtanga Samgraha of Vagbhata, Sootra Sthana; Dwividhopakramaniya Adhyaya: Chapter 24, Verse 10-16. Varanasi: Chowkhambha Sanskrit Series. 2006: 37-8.

5. Modak M, Dixit P, Londhe J, Ghaskadbi S, Devasagayam TP. Indian herbs and herbal drugs used for the treatment of diabetes. Journal of Clinical Biochemistry and Nutrition. 2007; 40(3):163-73. https://doi.org/10.3164/jcbn.40.163

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3